BANK OF AMERICA CORP /DE/ - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$99,308,000
-1.3%
838,685
-1.5%
0.01%
-15.4%
Q4 2020$100,573,000
-4.0%
851,521
-9.7%
0.01%
-7.1%
Q3 2020$104,801,000
+13.6%
942,959
+4.4%
0.01%0.0%
Q2 2020$92,265,000
-6.6%
902,971
-1.3%
0.01%
-22.2%
Q1 2020$98,736,000
-4.6%
914,817
+2.8%
0.02%
+20.0%
Q4 2019$103,530,000
+7.5%
889,586
+5.7%
0.02%
+7.1%
Q3 2019$96,303,000
+22.3%
841,295
+1.8%
0.01%
+16.7%
Q2 2019$78,743,000
-21.5%
826,258
-24.8%
0.01%
-25.0%
Q1 2019$100,305,000
+50.7%
1,099,229
+25.4%
0.02%
+33.3%
Q4 2018$66,546,000
-37.2%
876,641
-33.8%
0.01%
-29.4%
Q3 2018$106,018,000
+63.9%
1,325,220
+103.5%
0.02%
+54.5%
Q2 2018$64,690,000
+46.9%
651,261
+19.8%
0.01%
+37.5%
Q1 2018$44,039,000
+5626.8%
543,688
+5471.7%
0.01%
Q4 2017$769,000
-22.2%
9,758
-8.9%
0.00%
Q3 2017$988,00010,7080.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2020
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders